Chemicals and pharmaceuticals · MEIP

MEI Pharma, Inc.

40 filings mentioning 9 of the compliance and risk topics we track, most recently 2025-09-26. Every row links to the filing on EDGAR.

Page built . This page is derived from the framework corpus, which changes when the corpus is extended rather than daily.

40filings we hold
9topics disclosed
Chemicals and pharmaceuticalsindustry
CAbased in

Across 40 filings we hold, MEI Pharma, Inc. has written down 9 of the topics we track. That places it 14 of 755 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

MEI Pharma, Inc. has written 9 of our tracked topics into its filings. What it disclosed is public. What that now obligates is not, and it is 637 controls.From SEC filings and our framework corpus

What it discloses

Tracked topics appearing in this company's filings, most frequent first. Each opens the topic, where you can see who else files it and what it obligates.

TopicFilingsMost recent
Business Continuity202025-09-26
Regulatory Reporting142023-02-09
Restatement102025-03-07
Material Weakness82025-07-22
Internal Control82025-07-22
Data Breach22024-10-25
Data Governance22024-09-19
Enforcement Action12024-10-25
Artificial Intelligence12023-02-23

What this obligates

Every instrument below governs something MEI Pharma, Inc. has written into a filing. This maps to obligations within those frameworks. It is not a finding that the company has failed any of them, and nothing here establishes noncompliance.

10 frameworks, 637 controls between them, deduplicated across topics.

And what those same controls reach into

The controls behind those frameworks also appear in the instruments below, which suggests increased attention to them follows from the same work rather than from a separate programme.

ISO 27701:2019527
ISO 27002:2022497
PCI DSS 4.0168
COBIT 2019148
ISO/IEC 38500:2024144
NIS2 Directive86
ISO 22000:201846

Tell me when MEI Pharma, Inc. files something new

One email when there is a new SEC filing, naming what it is and what our corpus says it puts in scope. Nothing else, and one click to stop.

When it filed

Filings we hold, by year. Hover a bar for the count. Peak 11 in 2022.

19
20
21
22
23
24
25

Recent filings

FiledFormItem
2025-09-2610-Kfiling
2025-07-228-KEntry into a material agreement, Item 1.02, Item 3.02filing
2025-03-078-KDirector or officer departure, Financial statements and exhibitsfiling
2024-10-258-KEntry into a material agreement, Completion of an acquisition, Financial statements and exhibitsfiling
2024-09-1910-Kfiling
2024-05-0910-Qfiling
2024-02-218-KOther material event, Financial statements and exhibitsfiling
2024-02-1310-Qfiling
2023-12-268-KChange of accountant, Financial statements and exhibitsfiling
2023-11-0910-Qfiling
2023-09-2610-Kfiling
2023-06-138-KDirector or officer departure, Financial statements and exhibitsfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry classification. Each opens side by side with this one.

Where this goes next

  1. The topic MEI Pharma, Inc. files on most, and every other company that files on it:Business Continuity →
  2. How the rest of chemicals and pharmaceuticals compares, and who files most:Chemicals and pharmaceuticals →
  3. The failures that these disclosures usually turn out to be:How compliance programmes fail →
  4. What moved across every company we hold this week:What changed →
  5. And how much of any framework you are already carrying without knowing:What you already have →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down, in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition